+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The kinetic mechanism of S. pneumoniae DNA ligase and inhibition by adenosine-based antibacterial compounds



The kinetic mechanism of S. pneumoniae DNA ligase and inhibition by adenosine-based antibacterial compounds



Biochemical Pharmacology 84(5): 654-660



The NAD-dependent DNA ligase is an excellent target for the discovery of antibacterial agents with a novel mode of action. In this work the DNA ligase from Streptococcus pneumoniae was investigated for its steady-state kinetic parameters and inhibition by compounds with an adenosine substructure. Inhibition by substrate DNA that was observed in the enzyme turnover experiments was verified by direct binding measurements using isothermal titration calorimetry (ITC). The substrate-inhibited enzyme form was identified as deadenylated DNA ligase. The binding potencies of 2-(butylsulfanyl) adenosine and 2-(cyclopentyloxy) adenosine were not significantly affected by the presence of the enzyme-bound DNA substrate. Finally, a mutant protein was prepared that was known to confer resistance to the adenosine compounds' antibacterial activity. The mutant protein was shown to have little catalytic impairment yet it was less susceptible to adenosine compound inhibition.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056392912

Download citation: RISBibTeXText

PMID: 22743594

DOI: 10.1016/j.bcp.2012.06.017


Related references

Kinetic studies of platelet aggregation induced by adenosine diphosphate and its inhibition by chelating agents, guanidino compounds, and adenosine. Thrombosis et Diathesis Haemorrhagica 18(3-4): 713-725, 1967

Nucleic acid related compounds: 76. Synthesis of 5'(E and Z)-chloro-4',5'-didehydro-5'-deoxyadenosines via chlorination and thermolysis of adenosine-5'-sulfoxides: Mechanism-based inhibition of S-adenosyl-L-homocysteine hydrolase. Journal of Organic Chemistry 58(1): 111-117, 1993

Human placental adenosine kinase. Kinetic mechanism and inhibition. Journal of Biological Chemistry 255(11): 5264-5269, 1980

Integrating in vitro kinetic data from compounds exhibiting induction, reversible inhibition and mechanism-based inactivation: in vitro study design. Current Drug Metabolism 5(2): 141-146, 2004

Kinetic characteristics of the action of biologically active compounds. II. Effect of the inhibition mechanism on the efficacy of reversible enzyme inhibition. Pharmaceutical Chemistry Journal 27(11): 723-730, 1993

Kinetic features of effects of biologically active compounds: II. The impact of the mechanism of inhibition on the efficacy of reversible enzymatic inhibition. Khimiko-Farmatsevticheskii Zhurnal 27(11): 4-8, 1993

Kinetic mechanism and inhibition of Mycobacterium tuberculosis D-alanine:D-alanine ligase by the antibiotic D-cycloserine. Febs Journal 280(4): 1150-1166, 2013

Kinetic mechanism of mitochondrial adenosine triphosphatase. Inhibition by azide and activation by sulphite. Biochemical Journal 202(1): 15-23, 1982

Combined kinetic mechanism describing activation and inhibition of muscle glycogen phosphorylase b by adenosine 5'-monophosphate. Biophysical Chemistry 92(1-2): 89-102, 30 August, 2001

Kinetic mechanism of mitochondrial adenosine triphosphatase. ADP-specific inhibition as revealed by the steady-state kinetics. Biochemical Journal 202(1): 9-14, 1982

Adenosine phosphonate inhibitors of lipid II: alanyl tRNA ligase MurM from Streptococcus pneumoniae. Bioorganic and Medicinal Chemistry Letters 17(16): 4654-4656, 2007

Inhibition of adenosine cyclic 3', 5'-monophosphate accumulation in fat cells by adenosine, N6-(phenylisopropyl) adenosine, and related compounds. Molecular Pharmacology 9(5): 595-604, 1973

In vitro inhibition of adenosine deaminase by flavonoids and related compounds. New insight into the mechanism of action of plant phenolics. Methods and Findings in Experimental and Clinical Pharmacology 14(6): 413-417, 1992

A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds. Chemistry and Biology 16(8): 826-836, 2009

Analysis of Mechanism-Based Inhibition of CYP 3A4 by a Series of Fluoroquinolone Antibacterial Agents. Drug Metabolism and Disposition: the Biological Fate of Chemicals 44(10): 1608-1616, 2018